Skip to main content

Table 1 Results of the alignment

From: FusionSeq: a modular framework for finding gene fusions by analyzing paired-end RNA-sequencing data

Sample ID

Type

Known fusion type

Read size (nt)

Total number of PE reads

Mapped PE reads

Percentage of mapped PE reads

106_T

PCa

TMPRSS2-ERG

51

7,239,733

4,723,941

65.25%

1700_D

PCa

TMPRSS2-ERG

51

12,435,299

7,629,273

61.35%

580_B

PCa

TMPRSS2-ERG

36

18,134,550

7,690,673

42.41%

99_T

PCa

NDRG1-ERG

36

2,844,879

1,515,444

53.27%

2621_D

PCa

SLC45A3-ERG

54

22,079,700

11,899,984

53.90%

1043_D

PCa

No known fusions

51

3,003,305

1,898,332

63.21%

NCI-H660

PCa cell line

TMPRSS2-ERG

51

6,512,688

4,120,365

63.27%

GM12878

Lymphoblastoid cell line

No known fusions

54

44,829,991

20,676,159

46.12%

  1. Total number of PE reads, number of mapped PE reads and the percentage mapped are reported, Note that the number of single-end reads is double the number of PE reads. PCa, prostate cancer.